EP3 can promote tumor progression by enhancing migration, angiogenesis, and survival through ERK1/2, p53, EGFR, and TGFβ/Smad pathways, by increasing factors like PAI-1, uPAR, VEGF, and MMP9 [189,190,191,192]. This evidence concerns the gene TGFB1 and neoplasm.